November 22, 2026
IPB News logo IPB News We appreciate the underappreciated
Flash
Daily Updates

Antimicrobial Drugs: Centre Proposes Central Approval Before State Licence

Makers of antibiotics and similar medicines would face a central check before any state licence, and bulk-drug wholesalers would need their own licence form.

By IPB News Desk Reviewed by Shivanee Thote, Editorial Head 2 min read
A handful of antibiotic tablets and capsules

Image: Wikimedia Commons

The Union Health Ministry has proposed that manufacturers of antimicrobial medicines must get permission from the Central Licensing Authority before they apply to a state regulator for a manufacturing licence. The proposal is in a draft notification dated 6 November 2026, amending the New Drugs and Clinical Trials Rules, 2019, and was reported on 19 November by PTI. The ministry says licences have been granted for antimicrobial products “without adequate regulatory scrutiny” and wants substandard drugs kept out of the market. The draft invites objections and suggestions before the Centre finalises it.

State Licence Would Come Second

At present, state licensing authorities issue manufacturing licences for most antimicrobials. Under the draft, the word “antimicrobials” would be added to the definition of “new drug” in Rule 2(1)(w)(v), next to monoclonal antibodies. That would pull them under the central approval route. Companies that make antibiotic tablets, syrups or injections would need the central clearance first, then the state licence. Patients would not see a change at the pharmacy counter; the effect is on which products reach the shelf.

Gaps the Ministry Points To

The ministry says studies such as bioavailability and bioequivalence, and stability studies, may be missing for some antimicrobial products. It adds that substandard or ineffective antimicrobials “can contribute to the development and spread of antimicrobial resistance.” PTI noted that the G20 New Delhi Leaders’ Declaration backed a One Health approach to resistance.

Also read National Health Accounts: Households Still Pay 42.7% of Health Bill

Separate Licence for Bulk Drug Sellers

A second proposal, reported by IANS, would amend the Drugs Rules, 1945. One common licence now covers wholesale sale of both formulations and bulk drugs. The draft creates a separate application form and licence form for bulk drugs, listing the categories handled, including substances under the Narcotic Drugs and Psychotropic Substances Act, 1985. Sales would have to run under a competent person’s personal supervision.

Comment Deadline Not Yet Reported

None of the reports gives a deadline for comments or says when the rules could take effect. The draft is not final, and the ministry has not said how many existing licences it would affect.

Source: Based on reporting by ThePrint (PTI), IANS and Upstox.

Image: Wikimedia Commons.